141 related articles for article (PubMed ID: 10683080)
1. A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non--small-cell lung cancer.
Perng RP; Shih JF; Chen YM; Delgado FM; Tsai CM; Chou KC; Liu JM; Chern MS; Whang-Peng J
Am J Clin Oncol; 2000 Feb; 23(1):60-4. PubMed ID: 10683080
[TBL] [Abstract][Full Text] [Related]
2. Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.
Krzakowski M; Provencio M; Utracka-Hutka B; Villa E; Codes M; Kuten A; Henke M; Lopez M; Bell D; Biti G; Merimsky O; Beorchia A; Riggi M; Caux NR; Pouget JC; Dubray B; David P
J Thorac Oncol; 2008 Sep; 3(9):994-1002. PubMed ID: 18758302
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.
Lena MD; Ramlau R; Hansen O; Lorusso V; Wagner L; Barni S; Cristovao MM; Huber R; Alberola V; Mitrovic M; Colin C; Gasmi J
Lung Cancer; 2005 Apr; 48(1):129-35. PubMed ID: 15777980
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of i.v. vinorelbine and cisplatin in inoperable locally advanced or disseminated non-small-cell lung cancer: the South African experience.
Goedhals L; Vorobiof DA; Bezwoda W; Van Merwe A; Jordaan JP; Barnardt P; Smith BL
Curr Med Res Opin; 1999; 15(3):185-92. PubMed ID: 10621925
[TBL] [Abstract][Full Text] [Related]
5. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
[TBL] [Abstract][Full Text] [Related]
6. Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer.
Khuri FR; Rigas JR; Figlin RA; Gralla RJ; Shin DM; Munden R; Fox N; Huyghe MR; Kean Y; Reich SD; Hong WK
J Clin Oncol; 2001 May; 19(10):2626-37. PubMed ID: 11352954
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin, ifosfamide, and vinorelbine combination chemotherapy in stage III-IV non-small-cell lung cancer: a phase II study.
Rey F; Astoul P; Marqueste L; Petite JM; Boutin C; Viallat JR
Am J Clin Oncol; 1998 Oct; 21(5):518-22. PubMed ID: 9781613
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of a daily x4 schedule of vinorelbine plus cisplatin for advanced non-small cell lung cancer.
Han JY; Kim KW; Kim JA; Kang JH; Jin JY; Hong YS; Park SY; Song JS; Park JW; Kim HK; Lee KS; Choi BG
Jpn J Clin Oncol; 2000 Oct; 30(10):435-9. PubMed ID: 11185889
[TBL] [Abstract][Full Text] [Related]
9. Effect of vinorelbine, ifosfamide, and cisplatin combination chemotherapy in advanced non-small-cell lung cancer.
Ahn JB; Ko WK; Lee JG; Shim KY; Jeung HC; Park JO; Yoo NC; Kim BS; Kim SK; Kim SK; Kim JH
Am J Clin Oncol; 2000 Dec; 23(6):622-8. PubMed ID: 11202811
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of vinorelbine, mitomycin C and cisplatin chemotherapy for advanced non-small cell lung cancer.
Kwon MR; Jeong TY; Yuh YJ; Kim SR
Korean J Intern Med; 2002 Dec; 17(4):240-4. PubMed ID: 12647638
[TBL] [Abstract][Full Text] [Related]
11. Phase II study with vinorelbine and cisplatin in advanced non-small cell lung cancer after failure of previous chemotherapy.
Chen YM; Lee CS; Lin WC; Tsai CM; Perng RP
J Chin Med Assoc; 2003 Apr; 66(4):241-6. PubMed ID: 12854877
[TBL] [Abstract][Full Text] [Related]
12. A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (Stage IIIB/IV) non-small cell lung cancer.
Chen YM; Perng RP; Yang KY; Liu TW; Tsai CM; Ming-Liu J; Whang-Peng J
Chest; 2000 Jun; 117(6):1583-9. PubMed ID: 10858387
[TBL] [Abstract][Full Text] [Related]
13. The multifractionated, twice-weekly dose schedule for a three-drug chemotherapy regimen: a phase I-II study of paclitaxel, cisplatin, and vinorelbine.
Lokich JJ; Anderson N; Bern M; Coco F; Dow E
Cancer; 1999 Jan; 85(2):499-503. PubMed ID: 10023721
[TBL] [Abstract][Full Text] [Related]
14. Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancer.
Horvath L; Boyer M; Clarke S; Beale P; Beith J; Underhill C; Stockler M; Bishop J
Lung Cancer; 2001 May; 32(2):173-8. PubMed ID: 11325488
[TBL] [Abstract][Full Text] [Related]
15. Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1.
Robinet G; Thomas P; Breton JL; Léna H; Gouva S; Dabouis G; Bennouna J; Souquet PJ; Balmes P; Thiberville L; Fournel P; Quoix E; Riou R; Rebattu P; Pérol M; Paillotin D; Mornex F
Ann Oncol; 2001 Jan; 12(1):59-67. PubMed ID: 11249050
[TBL] [Abstract][Full Text] [Related]
16. Induction chemotherapy with cetuximab, vinorelbine-cisplatin followed by thoracic radiotherapy and concurrent cetuximab, vinorelbine-cisplatin in patients with unresectable stage III non-small cell lung cancer.
Liu D; Zheng X; Chen J; Liu G; Xu Y; Shen Y; Xie L; Zhao W; Jiang G; Fan M
Lung Cancer; 2015 Sep; 89(3):249-54. PubMed ID: 26118463
[TBL] [Abstract][Full Text] [Related]
17. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
[TBL] [Abstract][Full Text] [Related]
18. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.
Zatloukal P; Petruzelka L; Zemanova M; Havel L; Janku F; Judas L; Kubik A; Krepela E; Fiala P; Pecen L
Lung Cancer; 2004 Oct; 46(1):87-98. PubMed ID: 15364136
[TBL] [Abstract][Full Text] [Related]
19. Vinorelbine, ifosfamide, and cisplatin combination as salvage chemotherapy in advanced non-small cell lung cancer.
Song SY; Kim WS; Kim K; Jung CW; Im YH; Kim HJ; Kang WK; Lee HG; Kwon OJ; Rhee CH; Park CH; Park K
Jpn J Clin Oncol; 2003 Oct; 33(10):509-13. PubMed ID: 14623918
[TBL] [Abstract][Full Text] [Related]
20. Vinorelbine, ifosfamide and cisplatin as first-line treatment in patients with inoperable non-small cell lung cancer.
Montalar J; Morales S; Maestu I; Camps C; Vadell C; García R; Yuste AL; Torregrosa D; Segura A
Lung Cancer; 2001 Nov; 34(2):305-11. PubMed ID: 11679190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
